Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Business Roundup

April 16, 2022 | A version of this story appeared in Volume 100, Issue 13

 

Kraton, a maker of specialty polymers derived mainly from pine, plans to increase production capacity for alpha methyl styrene resins at its facility in Niort, France, by 15% by year-end. Kraton will also modify the plant to reduce solvent consumption by 70%.

Compact Membrane Systems (CMS) has started up a pilot membrane system at Braskem’s polypropylene plant in Marcus Hook, Pennsylvania. The unit, which uses CMS’s fluoropolymer-based membranes, will separate propylene from propane and run for 500 days.

Ascend Performance Materials, a maker of nylon 6,6, will acquire Formulated Polymers of Chennai, India. The nylon compounder manufactures in Chennai and has warehouses throughout India.

DIC of Japan has picked Good Chemistry, a Vancouver-based quantum chemistry firm, to provide it with quantum computing and artificial intelligence services. Good Chemistry’s cloud-based service will be applied to materials research at DIC.

e-Zinc has raised $25 million to begin pilot production of an energy storage system that uses a zinc-air battery to power businesses for several days. The company says its battery could increase the availability of renewable energy when other sources aren’t generating electricity.

Umiami has raised $29 million to build a factory that produces whole cuts of plant-based meat, rather than ground products like hamburgers or meatballs. The company plans to startwith a version of chicken breast.

Aurion Biotech has raised $120 million from investors including Visionary Ventures and KKR’s Falcon Vision unit. The firm is developing a cell therapy for treating a form of corneal edema, an eye disease.

Autigen has signed a research and licensing agreement with Boehringer Ingelheim aimed at finding therapies for people with sensorineural hearing loss. Autigen could get more than $100 million if it achieves all milestones.

Advertisement

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.